Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/19/17 → 9/12/19 |
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Treated Concomitantly with Rituximab or Cyclophospham
- Mohamed, Amr Ahmed (PI)